Friday, April 10, 2026 4:41:16 PM
I couldn’t understand what you were saying so I asked a few LLMs.
ChatGPT says: The post tries to sound authoritative but it’s mostly sarcasm and selective framing. Listing job titles and then claiming “no innovations tied to him” isn’t evidence of anything—it’s just an opinion presented as a résumé review. Turning that into proof that a technology is invalid is a logical leap.
Grok says:This is basically character attack dressed up as analysis. Showing a timeline and adding negative commentary next to each role doesn’t magically make it factual. It’s editorializing, not evidence.
Claude says: The argument relies on ridicule rather than substance. Mocking someone’s age or implying they’ve done nothing notable does not demonstrate anything about the underlying technology or company performance.
Copilot says: The graphic mixes verifiable items (job titles and dates) with subjective claims like “no innovations” or “limited traction.” Those judgments aren’t objective facts, yet they’re presented as if they are. That weakens the credibility of the entire argument.
ChatGPT says: The post tries to sound authoritative but it’s mostly sarcasm and selective framing. Listing job titles and then claiming “no innovations tied to him” isn’t evidence of anything—it’s just an opinion presented as a résumé review. Turning that into proof that a technology is invalid is a logical leap.
Grok says:This is basically character attack dressed up as analysis. Showing a timeline and adding negative commentary next to each role doesn’t magically make it factual. It’s editorializing, not evidence.
Claude says: The argument relies on ridicule rather than substance. Mocking someone’s age or implying they’ve done nothing notable does not demonstrate anything about the underlying technology or company performance.
Copilot says: The graphic mixes verifiable items (job titles and dates) with subjective claims like “no innovations” or “limited traction.” Those judgments aren’t objective facts, yet they’re presented as if they are. That weakens the credibility of the entire argument.
Recent RDGL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
